Latest Updates on Paraquat Parkinson’s Disease Lawsuits To Be Reviewed During MDL Conference on December 19

Lawyers will submit a one-page summary for each Paraquat bellwether lawsuit being prepared for early trial dates by December 16, which will be reviewed during a case management conference.

The U.S. District Judge presiding over all federal Paraquat Parkinson’s disease lawsuits will hold a status conference next week, to allow the parties to update the court on the status of the litigation, and progress preparing a second group of “bellwether” cases for early trial dates.

Syngenta and Chevron currently face more than 5,800 product liability lawsuits in the federal court system, each of which involve claims that the manufacturers failed to adequately disclose the link between use of Paraquat and Parkinson’s disease.

Due to the common questions of fact and law raised by users who were diagnosed with the devastating disease after regularly transporting, mixing and spraying the controversial weed killer, all federally-filed Paraquat lawsuits have been centralized before U.S. District Judge Nancy J. Rosenstengel in the Southern District of Illinois since June 2021, as part of a multidistrict litigation, or MDL.

PARAQUAT Parkinson's Lawsuits

Were you or a loved one exposed to Paraquat?

Lawyers are reviewing Paraquat lawsuits for individuals who were exposed to Paraquat and developed Parkinson's disease.

Learn More About This Lawsuit SEE IF YOU QUALIFY FOR COMPENSATION

Over the past three years, Judge Rosenstengel has been working with the parties to establish a bellwether process, where a small group of representative Paraquat lawsuits are being prepared for early test trials, to help the parties see how juries may respond to evidence and expert testimony that is likely to come up throughout the litigation.

However, earlier this year, Judge Rosenstengel dismissed a first batch of potential Paraquat bellwether cases, after excluding the plaintiff’s designated expert witness from testifying at trial. This left those claimants without any means to link their Parkinson’s disease diagnosis to Paraquat exposure.

In August, the Court selected 10 new Paraquat lawsuits to undergo case specific discovery in preparation for the bellwether trials, which will rely on different expert witness testimony than the previously dismissed claims. Judge Rosenstengel gave the parties until December 16 to turn in a one-page summary of each selected lawsuit.

In an order entered into the court docket on November 25, she announced that the next status conference will be held on December 19, three days after the case summary deadline.

No date for the first Paraquat bellwether trial has yet been set. When and if they do occur, they will be closely watched to see if the results can help the parties reach a potential Paraquat lawsuit settlement agreement. If not, Judge Rosenstengel would likely remand the cases back to their originating districts for individual trial dates.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Depo-Provera Class Action Lawsuit Seeks Medical Monitoring Due to Brain Tumor Risks
Depo-Provera Class Action Lawsuit Seeks Medical Monitoring Due to Brain Tumor Risks (Posted today)

Pfizer and other manufacturers of the Depo-Provera birth control shot have been included in a class action lawsuit seeking medical monitoring for women who received the injections, due to the increased risk of brain tumors.

Another Influx of Suboxone Tooth Decay Lawsuits Expected in Coming Months
Another Influx of Suboxone Tooth Decay Lawsuits Expected in Coming Months (Posted yesterday)

The number of Suboxone lawsuits is expected to surge once again this summer, before a potential statute of limitations deadline in June 2025, for claims from states with a three-year statute of limitations.